BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18988457)

  • 1. [Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry].
    Ziganshin RKh; Alekseev DG; Arapidi GP; Ivanov VT; Moshkovskiĭ SA; Govorun VM
    Biomed Khim; 2008; 54(4):408-19. PubMed ID: 18988457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Dai Y; Hu C; Wang L; Huang Y; Zhang L; Xiao X; Tan Y
    Scand J Rheumatol; 2010 May; 39(3):240-6. PubMed ID: 20166849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
    Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.
    Callesen AK; Madsen JS; Iachina M; Vach W; Kruse TA; Jensen ON; Mogensen O
    Cancer Biomark; 2010; 6(2):73-82. PubMed ID: 20571233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of a specific serum proteomic profile model of nasopharyngeal carcinoma by MALDI-TOF MS].
    Tao YL; Liu ZG; Xia YF; Yi W
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):188-91. PubMed ID: 21575517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
    Park CW; Jo Y; Jo EJ
    Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for the serum differential proteins of renal cell carcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu JS; Li HZ; Zhang YS; Wang P; Yan WG; Xie J; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):287-91. PubMed ID: 21718612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
    Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
    Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
    Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.